SCHEMBL5273263

SCHEMBL5273263

OCCCCCc1nn(Cc2ccc(Cl)cc2F)c2cc(C(F)(F)F)ccc12

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.41
NR1H3 Q13133 2/20 0.41
AKR1B1 P15121 2/20 0.38
PTGER4 P35408 1/20 0.36
GRM2 Q14416 1/20 0.36
VNN1 O95497 1/20 0.36
CYP2C9 P11712 4/20 0.35
SLC22A12 Q96S37 1/20 0.35
CYP3A4 P08684 3/20 0.33
CYP2C19 P33261 3/20 0.33
CCR2 P41597 1/20 0.33
PKM P14618 1/20 0.33
PKLR P30613 1/20 0.33
ENPP2 Q13822 1/20 0.33
CYP2D6 P10635 1/20 0.33
PDE5A O76074 1/20 0.33
KLKB1 P03952 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5318908 0.99 NR1H2 (0.42) NR1H2NR1H3AKR1B1PTGER4GRM2
SCHEMBL5320313 0.96 NR1H2 (0.42) NR1H2NR1H3AKR1B1PTGER4GRM2
SCHEMBL5267313 0.92 NR1H2 (0.44) NR1H2NR1H3AKR1B1PTGER4GRM2
SCHEMBL5317364 0.91 NPSR1 (0.41) NR1H2NR1H3AKR1B1CYP2C9SLC22A12
SCHEMBL5322190 0.90 NPSR1 (0.41) NR1H2NR1H3AKR1B1CYP2C9SLC22A12
SCHEMBL5316868 0.90 KCNK3 (0.38) NR1H2NR1H3AKR1B1PTGER4VNN1
SCHEMBL5317869 0.89 AKR1B1 (0.37) NR1H2NR1H3AKR1B1PTGER4CYP2C9
SCHEMBL5317824 0.89 KCNK3 (0.39) NR1H2NR1H3AKR1B1PTGER4VNN1
SCHEMBL5317649 0.88 AKR1B1 (0.38) NR1H2NR1H3AKR1B1PTGER4CYP2C9
SCHEMBL5317815 0.88 AKR1B1 (0.43) NR1H2NR1H3AKR1B1PTGER4VNN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed